Michael-John Devlin
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 6
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Martin David Forster (1 shared paper)Tim Meyer (1 shared paper)Jean‐Pierre Delord (1 shared paper)Valentina Boni (1 shared paper)Suzanne Louise Topalian (1 shared paper)Ibrahima Soumaoro (1 shared paper)Joseph N. Kerger (1 shared paper)Tian Chen (1 shared paper)
- Journals
- International Journal of Gynecological Cancer (2 papers)Journal of Clinical Oncology (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Gynecologic Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Michael-John Devlin
10 papers receiving 611 citations
Michael-John Devlin's Hit Papers
Peers
Comparison fields: 5 of 36
- Obstetrics and Gynecology 154
- Oncology 299
- Reproductive Medicine 120
- Otorhinolaryngology 45
- Cancer Research 39
Countries citing papers authored by Michael-John Devlin
This map shows the geographic impact of Michael-John Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael-John Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael-John Devlin more than expected).
Fields of papers citing papers by Michael-John Devlin
This network shows the impact of papers produced by Michael-John Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael-John Devlin. The network helps show where Michael-John Devlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael-John Devlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial Hit paper breakdown → | 2019 | 355 |
| 2 | 2018 | 96 | |
| 3 | 2019 | 89 | |
| 4 | 2022 | 29 | |
| 5 | 2024 | 27 | |
| 6 | 2025 | 19 | |
| 7 | 2022 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2018 | 0 |
About Michael-John Devlin
Michael-John Devlin is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 621 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), Cervical Cancer and HPV Research (1 paper), Ethics in Clinical Research (1 paper), Breast Cancer Treatment Studies (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Obstetrics and Gynecology (154 citations), Oncology (299 citations), Reproductive Medicine (120 citations), Otorhinolaryngology (45 citations) and Cancer Research (39 citations). Michael-John Devlin has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Martin David Forster, Tim Meyer, Jean‐Pierre Delord, Valentina Boni, Suzanne Louise Topalian, Ibrahima Soumaoro, Joseph N. Kerger, Tian Chen, Kathleen N. Moore and Thomas R. Jeffry Evans. Their work appears in journals such as International Journal of Gynecological Cancer, Journal of Clinical Oncology, Therapeutic Advances in Medical Oncology, Gynecologic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.